IBDEI0E3 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6789,0)
 ;;=250.60^^55^572^62
 ;;^UTILITY(U,$J,358.3,6789,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6789,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,6789,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,6789,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,6790,0)
 ;;=356.9^^55^572^64
 ;;^UTILITY(U,$J,358.3,6790,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6790,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,6790,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,6790,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,6791,0)
 ;;=780.2^^55^572^73
 ;;^UTILITY(U,$J,358.3,6791,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6791,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,6791,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,6791,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,6792,0)
 ;;=724.3^^55^572^70
 ;;^UTILITY(U,$J,358.3,6792,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6792,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,6792,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,6792,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,6793,0)
 ;;=780.39^^55^572^72
 ;;^UTILITY(U,$J,358.3,6793,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6793,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,6793,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,6793,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,6794,0)
 ;;=782.0^^55^572^60
 ;;^UTILITY(U,$J,358.3,6794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6794,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,6794,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,6794,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,6795,0)
 ;;=435.9^^55^572^74
 ;;^UTILITY(U,$J,358.3,6795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6795,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,6795,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,6795,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,6796,0)
 ;;=354.2^^55^572^76
 ;;^UTILITY(U,$J,358.3,6796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6796,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,6796,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,6796,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,6797,0)
 ;;=729.1^^55^572^17
 ;;^UTILITY(U,$J,358.3,6797,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6797,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,6797,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,6797,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,6798,0)
 ;;=438.20^^55^572^6
 ;;^UTILITY(U,$J,358.3,6798,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6798,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,6798,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,6798,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,6799,0)
 ;;=438.12^^55^572^5
 ;;^UTILITY(U,$J,358.3,6799,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6799,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,6799,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,6799,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,6800,0)
 ;;=356.8^^55^572^63
 ;;^UTILITY(U,$J,358.3,6800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6800,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,6800,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,6800,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,6801,0)
 ;;=337.20^^55^572^68
 ;;^UTILITY(U,$J,358.3,6801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6801,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,6801,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,6801,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,6802,0)
 ;;=294.8^^55^572^14
 ;;^UTILITY(U,$J,358.3,6802,1,0)
 ;;=^358.31IA^5^2
